Hos transplantationspatienter er langvarig systemisk og intens immunosuppression efter systemisk administration af calcinurinhæmmere associeret med en øget risiko for udvikling af lymfomer og hudmaligniteter.
In transplant patients, prolonged systemic exposure to intense immunosuppression following systemic administration of calcineurin inhibitors has been associated with an increased risk of developing lymphomas and skin malignancies.